glp-1 lean mass loss agonists and changes in body and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis GLP1 Muscle Loss

Searching for insulin-releasing peptides in the gut In the course of their research, Marks and Samols began to wonder whether the ingestion of glucose was due to an incretin-like substance originating from the gut which echoed with the incretin concept

Larry Hornsby, chairman of the board for WCP added, At Wellstar, we all work together to keep our communities healthy

Prescription GLP-1 Medications (Wegovy, Ozempic, Zepbound): These are FDA-approved pharmaceutical products that have undergone extensive clinical trials demonstrating safety and efficacy

Instead, clinicians should acknowledge this risk and consider individualized risk-benefit strategies when prescribing GLP-1 RAs, particularly for patients with pre-existing ocular manifestations and must inform patients regarding possible ocular hazards while advocating for regular retinal examinations and assessments of visual acuity

Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)